Advancing IBD Therapy by Sharing New Clinical Insights & Future Directions of Recent Approvals

• Discover the latest clinical data and real-world insights to understand impacts on patient outcomes in Ulcerative Colitis and Crohn’s disease
• Learn how recent regulatory approvals are expanding treatment options and improving access for patients with IBD
• Explore future directions in IBD care by examining ongoing research, pipeline developments, and strategies for integrating new therapies into clinical practice

Speakers:

Bradford McRae

Senior Director - Immunology Translational Sciences, Gastroenterology

Johnson & Johnson